<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E3B20713-956F-4D17-9AF7-B561CCBAE326"><gtr:id>E3B20713-956F-4D17-9AF7-B561CCBAE326</gtr:id><gtr:name>University of Bologna</gtr:name><gtr:address><gtr:line1>Via Irnerio 46</gtr:line1><gtr:postCode>40126</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/72D3BE82-7A22-490E-AFCF-06D8EEF58D0B"><gtr:id>72D3BE82-7A22-490E-AFCF-06D8EEF58D0B</gtr:id><gtr:name>Angers University Hospital (CHU Angers)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89D5574C-AAF7-4D96-832C-C2BA623123CE"><gtr:id>89D5574C-AAF7-4D96-832C-C2BA623123CE</gtr:id><gtr:name>Eberhard Karls University Tuebingen</gtr:name><gtr:address><gtr:line1>Wilhelmstra?e 7</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Institute of Neuroscience</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E3B20713-956F-4D17-9AF7-B561CCBAE326"><gtr:id>E3B20713-956F-4D17-9AF7-B561CCBAE326</gtr:id><gtr:name>University of Bologna</gtr:name><gtr:address><gtr:line1>Via Irnerio 46</gtr:line1><gtr:postCode>40126</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/72D3BE82-7A22-490E-AFCF-06D8EEF58D0B"><gtr:id>72D3BE82-7A22-490E-AFCF-06D8EEF58D0B</gtr:id><gtr:name>Angers University Hospital (CHU Angers)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89D5574C-AAF7-4D96-832C-C2BA623123CE"><gtr:id>89D5574C-AAF7-4D96-832C-C2BA623123CE</gtr:id><gtr:name>Eberhard Karls University Tuebingen</gtr:name><gtr:address><gtr:line1>Wilhelmstra?e 7</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CEB540EB-ABDC-478D-9603-4B8FDCE01F15"><gtr:id>CEB540EB-ABDC-478D-9603-4B8FDCE01F15</gtr:id><gtr:firstName>Patrick</gtr:firstName><gtr:surname>Yu Wai Man</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701386"><gtr:id>2DEC7F74-0BC3-4076-AD1A-2DE808749BD8</gtr:id><gtr:title>Do secondary mitochondrial DNA defects cause retinal ganglion cell death in dominant optic atrophy?</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0701386</gtr:grantReference><gtr:abstractText>Dominant optic atrophy (DOA) is one of the commonest form of inherited blindness and it results in significant visual disability. DOA is caused by irreversible damage to the optic nerve, which connects the eye to the vision centres within the brain. It is a specialised cable made up of about 2 million, highly specialised cells known as retinal ganglion cells (RGCs). In 60-70% of cases, DOA is due to a mutation in the OPA1 gene but we still do not know how this genetic defect leads to disease and why only RGCs are affected. Our preliminary findings in one large family with DOA indicate that the OPA1 mutation compromises the normal function of mitochondria. Mitochondria are essential components of all human cells and they are responsible for energy production. If insufficient energy is produced, cells cannot function properly and die. To test my hypothesis further, I will analyse blood and muscle biopsies from additional families with DOA for evidence of mitochondrial dysfunction. I will also analyse RGCs from a mouse model of DOA and determine if they contain high levels of mitochondrial DNA abnormalities. Finally, I will try to identify the gene(s) responsible for DOA in those families who not carry an OPA1 mutation. RGCs are affected in other eye conditions like glaucoma and a better understanding of their selective vulnerability will help us develop more effective treatment strategies for these blinding diseases.</gtr:abstractText><gtr:technicalSummary>Dominant optic atrophy (DOA) is the most common inherited optic neuropathy and it is characterised by the progressive, focal neurodegeneration of the retinal ganglion cell (RGC) layer. DOA causes significant visual handicap, has no cure, and ~60% of cases are due to mutations in the OPA1 gene (3q28-q29). However, it is not yet established how the mutant Opa1 protein leads to disease and why RGCs are selectively targeted.
Mitochondria contain multiple copies of their own DNA (mtDNA) and both mutations (deletions and point mutations) and a reduction in the number of mtDNA molecules (depletion) can trigger a bioenergetic defect. I have recently characterised a large OPA1 family with histochemical evidence of mitochondrial dysfunction and cytochrome c oxidase negative (COX-negative) fibres in limb muscle which contained high-levels of pathogenic mtDNA deletions. Five other families with DOA have since been found to harbour multiple mtDNA deletions, only three of which had OPA1 mutations.
Our preliminary data therefore suggest that (i) the Opa1 protein is involved in mtDNA maintenance (ii) the accumulation of secondary (2 ) mtDNA defects is central to the pathophysiology of DOA and (iii) some families with DOA are likely to harbour as yet unidentified nuclear genes involved in mtDNA maintenance.
(1) Do secondary mtDNA defects lead to RGC death in DOA?
I will sequence the OPA1 gene in ten additional families with a clinical diagnosis of DOA and look for COX deficiency in limb muscle biopsies. Using laser microdissection, I will then capture single COX-negative muscle fibres and assess whether detrimental levels of 2 mtDNA defects are present (point mutations, deletions and depletion). I will also compare the range of mtDNA defects observed in these families with those seen in other disorders of mtDNA maintenance and attempt genotype-phenotype correlations. Finally, using a mouse model of DOA, I will determine whether the level of apoptosis and proportion of COX-negative cells is higher in RGCs compared to other tissues.
(2) Is DOA caused by other nuclear genes involved in mtDNA maintenance?
Through an existing collaborative network, I have access to a group of families with DOA but no OPA1 mutations. I will perform linkage analysis on these families to search for novel DOA loci and using bioinformatic techniques, I will identify and sequence candidate genes implicated in mtDNA maintenance within these regions.
Other optic neuropathies, including glaucoma, preferentially affect RGCs and understanding why these cells are selectively vulnerable will have broad implications.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>197281</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Optometry and Vision Sciences</gtr:department><gtr:description>Cardiff OPA1 Mouse Collaboration</gtr:description><gtr:id>630A0446-6758-4DD0-969D-68D25BF7BAAE</gtr:id><gtr:impact>PMID: 19443720
PMID: 20157015</gtr:impact><gtr:outcomeId>0DB41A7F3A1-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators in Cardiff have provided us with tissues from an OPA1 mouse model of dominant optic atrophy.</gtr:partnerContribution><gtr:piContribution>I have analysed these OPA1 mouse tissues as part of my ongoing PhD research project.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health and Medical Research (INSERM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Institute of Neuroscience Montpellier</gtr:department><gtr:description>Montpellier OPA1 Collaboration</gtr:description><gtr:id>A50035B2-5D4F-4229-AB0B-C49F903F5E38</gtr:id><gtr:impact>PMID: 20974897
PMID: 20157015</gtr:impact><gtr:outcomeId>YPHdarMLtNn-1</gtr:outcomeId><gtr:partnerContribution>Dr Leaners' team have provided tissue samples and experimental data for our research in Newcastle.</gtr:partnerContribution><gtr:piContribution>We are working with Dr Guy Lenaers team in Montpellier to investigate the role of OPA1 in mitochondrial DNA replication.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eberhard Karls University of Tubingen</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute for Ophthalmic Research</gtr:department><gtr:description>Tuebingen OPA1 Mouse Collaboration</gtr:description><gtr:id>D934D900-9259-42BE-A79D-407939E48167</gtr:id><gtr:impact>PMID: 19815013
PMID: 19181907</gtr:impact><gtr:outcomeId>4C924CBA2F4-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators in Tuebingen have provided us with tissues from a second OPA1 mouse model of dominant optic atrophy - different from the Cardiff one.</gtr:partnerContribution><gtr:piContribution>I have analysed these OPA1 mouse tissues as part of my ongoing PhD research project.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bologna</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Department of Neurologial Sciences</gtr:department><gtr:description>Bologna OPA1 Collaboration</gtr:description><gtr:id>2575129A-3F31-4F31-B8B8-761A4D35A61A</gtr:id><gtr:impact>PMID: 20974897
PMID: 20157015</gtr:impact><gtr:outcomeId>PhZ8E8vPjct-1</gtr:outcomeId><gtr:partnerContribution>Dr Carelli's team have provided us with clinical data for a meta-analysis of the phenotypes seen in patients with OPA1 mutations.</gtr:partnerContribution><gtr:piContribution>We are working closely with Dr Carelli's team in Bologa to understand the development of multisystem disease in patients harbouring OPA1 mutations.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Angers University Hospital (CHU Angers)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Department of Biochemistry and Genetics</gtr:department><gtr:description>Angers OPA1 Collaboration</gtr:description><gtr:id>ED4837D4-7597-4356-A08C-AE8531459CFD</gtr:id><gtr:impact>PMID:20974897
PMID:20157015</gtr:impact><gtr:outcomeId>nLbecGjd1Qj-1</gtr:outcomeId><gtr:partnerContribution>Exchange of patient data and tissue samples</gtr:partnerContribution><gtr:piContribution>Exchange of patient data and tissue samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>EUROMIT 7 - Stockholm 2008</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>249ADB62-7089-4D9C-93E0-3E63F0C8F9F2</gtr:id><gtr:impact>Posters presented at EUROMIT 7 which is the largest meeting devoted to research into mitochondrial disorders.

New collaborations</gtr:impact><gtr:outcomeId>81745B16363</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ARVO - Florida 2008</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DE4FD2EE-F18D-4E3E-907E-F22F1AC77607</gtr:id><gtr:impact>Oral presentation at ARVO, which is the largest annual scientific meeting devoted to basic research into eye disorders.

New collaborations</gtr:impact><gtr:outcomeId>30E12033855</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Fighting Blindness - Dublin 2009</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>530E370F-296F-4F1D-AF1B-64A99B80D38E</gtr:id><gtr:impact>Meeting on translational eye research. The participants came from various backgrounds: clinicians, scientists, and patient groups - both local and international.

New collaborations - especially with international patient associations involved in the fight against blindness.</gtr:impact><gtr:outcomeId>B13344B9782</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1126871</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>What disease mechanisms contribute to multisystem tissue involvement in dominant optic atrophy due to OPA1 mutations?</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>0635CB59-EAF2-4E3A-B9A2-B2CD6A44C252</gtr:id><gtr:outcomeId>mjKRZqQZHJE0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>310000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Biomedical Research Centre</gtr:department><gtr:description>NIHR Rare Diseases Translational Research Collaboration</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>59ED400C-13DD-44C1-87D3-5AF9EA2D8C83</gtr:id><gtr:outcomeId>56c11637344bf0.94684378</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>130000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Moorfields Special Trustees Research Award</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Moorfields Eye Charity</gtr:fundingOrg><gtr:id>935EFC44-24CD-463E-A00A-6DE97C734830</gtr:id><gtr:outcomeId>58ae25eef2da38.28095934</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centenary Early Career Award</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1024AAE6-6D74-4E98-928F-AC39DBC0790A</gtr:id><gtr:outcomeId>cSG3rrrLvEN</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Rare Diseases Translational Research Collaboration</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>440F6BC7-71E2-4DD9-BAA2-E08AB14BE1D5</gtr:id><gtr:outcomeId>jJnNkVPVorF</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>An extensive up-to-date database of patients with inherited eye diseases, with a primary focus on mitochondrial genetic disorders.</gtr:description><gtr:id>5BF148B1-CF88-4746-9C90-4723D43EBDAE</gtr:id><gtr:impact>DOA and LHON are the two most commmon inherited optic nerve disorders in the general population. This database has allowed us to define the epidemiology of autosomal dominant optic atrophy (DOA) in the North of England and has contributed to the successful completion of a Phase II randomised controlled trial for Leber Hereditary Optic Neuropathy (LHON).</gtr:impact><gtr:outcomeId>B631FC463D7</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Inherited Eye Diseases Database</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Setting up of fibroblasts and myoblast cell lines carrying pathogenic OPA1 mutations.</gtr:description><gtr:id>2CD7451A-6439-460D-ADCF-51213BCB8C85</gtr:id><gtr:impact>This valuable tissue biobank will be used for future projects looking at OPA1 disease mechanisms.</gtr:impact><gtr:outcomeId>E2E47442B6A</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>OPA1 Tissue Biobank</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C5DAC497-76E4-4BB6-944C-71D0E910443A</gtr:id><gtr:title>The neurological and ophthalmological manifestations of SPG4-related hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89b31b53bd8d22167e3e61b6f878f7e4"><gtr:id>89b31b53bd8d22167e3e61b6f878f7e4</gtr:id><gtr:otherNames>Guthrie G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_13449_29_23238845</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E17D4F6-7244-4E9F-8D5F-172C7D77A26F</gtr:id><gtr:title>Clinical utility gene card for: Wolfram syndrome.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca156e6df4ad3e8526f06caa371e7fbf"><gtr:id>ca156e6df4ad3e8526f06caa371e7fbf</gtr:id><gtr:otherNames>Moosajee M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>58a4eb85267534.96487567</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>024DEEDD-7560-4FCF-9956-669217332895</gtr:id><gtr:title>Disorders of the optic nerve in mitochondrial cytopathies: new ideas on pathogenesis and therapeutic targets.</gtr:title><gtr:parentPublicationTitle>Current neurology and neuroscience reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/110e3dc589769ce84dec29b85162fcd3"><gtr:id>110e3dc589769ce84dec29b85162fcd3</gtr:id><gtr:otherNames>Sitarz KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1528-4042</gtr:issn><gtr:outcomeId>pm_13449_29_22392506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DFD8249-6D9D-48D1-B5E0-40990A11759D</gtr:id><gtr:title>Reply: Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7001a629b2674273a8490bc6a5efa6a3"><gtr:id>7001a629b2674273a8490bc6a5efa6a3</gtr:id><gtr:otherNames>Bannwarth S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>544972b2c8c5b6.27722924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E1C1B84-46AD-4EBE-8C16-01B36A7F3D8A</gtr:id><gtr:title>The Pattern of Retinal Ganglion Cell Loss in OPA1-Related Autosomal Dominant Optic Atrophy Inferred From Temporal, Spatial, and Chromatic Sensitivity Losses.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b59fc60f985bd8aacf9bde6a7f490cf9"><gtr:id>b59fc60f985bd8aacf9bde6a7f490cf9</gtr:id><gtr:otherNames>Majander A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>58a4eb845b95a0.80474872</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>770F6A4E-7A20-43E6-B455-355654E7716F</gtr:id><gtr:title>Mitochondrial donation--how many women could benefit?</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/259bacbf5a696ae04385c90a10e4ab61"><gtr:id>259bacbf5a696ae04385c90a10e4ab61</gtr:id><gtr:otherNames>Gorman GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>56bfcec17fd426.40565102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61DB5C3D-1A78-435F-B878-488CAFDE50E3</gtr:id><gtr:title>Treatment strategies for inherited optic neuropathies: past, present and future.</gtr:title><gtr:parentPublicationTitle>Eye (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0950-222X</gtr:issn><gtr:outcomeId>544972b43e6278.91465272</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DE955F7-CF90-4173-9E45-2C000BDBE574</gtr:id><gtr:title>Recessive Mutations in RTN4IP1 Cause Isolated and Syndromic Optic Neuropathies.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5372d563a7bb47af0e0d4f7f0e0af9da"><gtr:id>5372d563a7bb47af0e0d4f7f0e0af9da</gtr:id><gtr:otherNames>Angebault C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>56bfcebfcfac40.27199436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED9C50D4-885D-4577-9D84-96119E278BB9</gtr:id><gtr:title>Neuro-Ophthalmology in the United Kingdom.</gtr:title><gtr:parentPublicationTitle>Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1070-8022</gtr:issn><gtr:outcomeId>56bfcec0ecc1d4.78117822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E653A10-D201-42E6-9DFD-93F4D6C3893E</gtr:id><gtr:title>Lamination of the Outer Plexiform Layer in Optic Atrophy Caused by Dominant WFS1 Mutations.</gtr:title><gtr:parentPublicationTitle>Ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b59fc60f985bd8aacf9bde6a7f490cf9"><gtr:id>b59fc60f985bd8aacf9bde6a7f490cf9</gtr:id><gtr:otherNames>Majander A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0161-6420</gtr:issn><gtr:outcomeId>58a4eb859145c6.28222260</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB96BE7A-1773-4668-BC1E-D1E4F40A80F2</gtr:id><gtr:title>Reply: Are CHCHD10 mutations indeed associated with familial amyotrophic lateral sclerosis?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7001a629b2674273a8490bc6a5efa6a3"><gtr:id>7001a629b2674273a8490bc6a5efa6a3</gtr:id><gtr:otherNames>Bannwarth S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5675dc6f8d1c3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC58C466-1FB7-4170-BBB2-B2D00B076079</gtr:id><gtr:title>Inherited mitochondrial optic neuropathies.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>58a4ec2f41d033.48724350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F7488D2-B09C-4A9C-8087-7F3E6368EFFA</gtr:id><gtr:title>Reply: Early-onset Behr syndrome due to compound heterozygous mutations in OPA1.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>544972b36561f1.56440234</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9462F8C-97B1-414D-AE24-3A44C3FD52D2</gtr:id><gtr:title>Fatal infantile mitochondrial encephalomyopathy, hypertrophic cardiomyopathy and optic atrophy associated with a homozygous OPA1 mutation.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/900f2596778f7b8a20c902800109b43b"><gtr:id>900f2596778f7b8a20c902800109b43b</gtr:id><gtr:otherNames>Spiegel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>56bfcebe9504b4.19672682</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D8201A5-BBC5-48C6-B260-D8C8BEE09D02</gtr:id><gtr:title>Harnessing the Power of Genetic Engineering for Patients With Mitochondrial Eye Diseases.</gtr:title><gtr:parentPublicationTitle>Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1070-8022</gtr:issn><gtr:outcomeId>58a4eb83d53374.68212825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A5F531D-5B42-4662-8B0B-822167AF6FD6</gtr:id><gtr:title>Reply: CHCHD10 mutations in Italian patients with sporadic amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7001a629b2674273a8490bc6a5efa6a3"><gtr:id>7001a629b2674273a8490bc6a5efa6a3</gtr:id><gtr:otherNames>Bannwarth S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5675de75dee8b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F97409EF-7FC1-4C62-82F9-41CBEE4A63A8</gtr:id><gtr:title>Subtle neurological and metabolic abnormalities in an Opa1 mouse model of autosomal dominant optic atrophy.</gtr:title><gtr:parentPublicationTitle>Experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/265a132367fcbc18d9397f7cf301f35c"><gtr:id>265a132367fcbc18d9397f7cf301f35c</gtr:id><gtr:otherNames>Alavi MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-4886</gtr:issn><gtr:outcomeId>GwT9dkJKSpA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14A5BFF3-3CD4-4BBB-BEC3-5869E5677954</gtr:id><gtr:title>OPA1 mutations induce mtDNA proliferation in leukocytes of patients with dominant optic atrophy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/110e3dc589769ce84dec29b85162fcd3"><gtr:id>110e3dc589769ce84dec29b85162fcd3</gtr:id><gtr:otherNames>Sitarz KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_13449_29_22993284</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9610E926-22D2-4EE7-A7BC-9691D9FC2330</gtr:id><gtr:title>Disturbed mitochondrial dynamics and neurodegenerative disorders.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f2bc8ccf2f361fa8c5a2eebff8fa9de"><gtr:id>1f2bc8ccf2f361fa8c5a2eebff8fa9de</gtr:id><gtr:otherNames>Burt? F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>56bfcd19dc2223.53537248</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C00912D-7EBC-4F11-BEE8-3D642AC56B96</gtr:id><gtr:title>Genetic variations within the OPA1 gene are not associated with neuromyelitis optica.</gtr:title><gtr:parentPublicationTitle>Multiple sclerosis (Houndmills, Basingstoke, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/110e3dc589769ce84dec29b85162fcd3"><gtr:id>110e3dc589769ce84dec29b85162fcd3</gtr:id><gtr:otherNames>Sitarz KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1352-4585</gtr:issn><gtr:outcomeId>C49b8szagLE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59FB81FC-4D53-448F-AF65-A8D4DC6AAB04</gtr:id><gtr:title>Reply: A distinct clinical phenotype in a German kindred with motor neuron disease carrying a CHCHD10 mutation.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7001a629b2674273a8490bc6a5efa6a3"><gtr:id>7001a629b2674273a8490bc6a5efa6a3</gtr:id><gtr:otherNames>Bannwarth S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56bfcec0bdbf44.49073563</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE09E73F-861A-4CA7-A86D-BC37607EB1DA</gtr:id><gtr:title>Prevalence of neurogenetic disorders in the North of England.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c967a786847e7e5db1d802a30f49fbb9"><gtr:id>c967a786847e7e5db1d802a30f49fbb9</gtr:id><gtr:otherNames>Bargiela D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>56bfcec02c3807.25811329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>151E9980-F8E3-4D1B-BC8A-E648355D701C</gtr:id><gtr:title>New treatments for mitochondrial disease-no time to drop our standards.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8e8b394438d706d8ec79a1881109468"><gtr:id>b8e8b394438d706d8ec79a1881109468</gtr:id><gtr:otherNames>Pfeffer G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>pm_13449_29_23817350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDD35901-3F41-4C77-A2A0-7638867435FB</gtr:id><gtr:title>Leber Hereditary Optic Neuropathy - Therapeutic Challenges and Early Promise.</gtr:title><gtr:parentPublicationTitle>Taiwan journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2211-5056</gtr:issn><gtr:outcomeId>5675e042e84a8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E974B8D1-470E-4197-BB7B-5D1FF2ADE8D4</gtr:id><gtr:title>Prominent sensorimotor neuropathy due to SACS mutations revealed by whole-exome sequencing.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aec7e888ca27cb54fb6a199e4662974"><gtr:id>6aec7e888ca27cb54fb6a199e4662974</gtr:id><gtr:otherNames>Pyle A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>pm_13449_29_22751902</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FF2255E-E6BA-4E13-8E49-0E7E19678DE0</gtr:id><gtr:title>Efficacy of intracameral and subconjunctival cefuroxime in preventing endophthalmitis after cataract surgery.</gtr:title><gtr:parentPublicationTitle>Journal of cataract and refractive surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0886-3350</gtr:issn><gtr:outcomeId>58a4ec2fb0eb33.82315270</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>082E789F-C520-4EE4-A69C-B50F1A264FFE</gtr:id><gtr:title>Gene-environment interactions in Leber hereditary optic neuropathy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0faae46ebf735b7d8137ebba519be0a0"><gtr:id>0faae46ebf735b7d8137ebba519be0a0</gtr:id><gtr:otherNames>Kirkman MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>fGo5b5NTFu8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA33C5AB-7CE8-43BE-93F9-FCF52DFFEE2A</gtr:id><gtr:title>Spastic paraplegia in 'dominant optic atrophy plus' phenotype due to OPA1 mutation.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd0b13822add65b21833f84ffd4ef93f"><gtr:id>bd0b13822add65b21833f84ffd4ef93f</gtr:id><gtr:otherNames>Pretegiani E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5a327984ca8aa3.20402062</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48828CAF-22C9-4D52-8CAA-2DC7E5C91318</gtr:id><gtr:title>OPA1 in multiple mitochondrial DNA deletion disorders.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/694f8cf95736b2802883926f906e6121"><gtr:id>694f8cf95736b2802883926f906e6121</gtr:id><gtr:otherNames>Stewart JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>EF30FBD8BF1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0732597C-9317-4ABC-8791-05D8F332CCB8</gtr:id><gtr:title>The clinical spectrum of mitochondrial genetic disorders.</gtr:title><gtr:parentPublicationTitle>Clinical medicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0faae46ebf735b7d8137ebba519be0a0"><gtr:id>0faae46ebf735b7d8137ebba519be0a0</gtr:id><gtr:otherNames>Kirkman MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1470-2118</gtr:issn><gtr:outcomeId>D0331D78BF8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95FC202C-0C93-4FF8-AB3B-8A9CB7697491</gtr:id><gtr:title>A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6eb36c645750836ba7b7fb501797c8d9"><gtr:id>6eb36c645750836ba7b7fb501797c8d9</gtr:id><gtr:otherNames>Klopstock T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>AQx81equatx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66B77DEF-6342-4DB6-B456-0A5E8C282758</gtr:id><gtr:title>CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c3b332cbef779a7f83a52cbb472984b"><gtr:id>8c3b332cbef779a7f83a52cbb472984b</gtr:id><gtr:otherNames>Genin EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn><gtr:outcomeId>56bfcebf7ebf31.99906661</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB713D25-C832-4FBA-923B-B4437A012492</gtr:id><gtr:title>OPA1 mutations impair mitochondrial function in both pure and complicated dominant optic atrophy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>58a4ec2d2fc188.92118929</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FDC6F42-C7FE-4CA7-A332-2ABACEE07338</gtr:id><gtr:title>Traumatic optic neuropathy-Clinical features and management issues.</gtr:title><gtr:parentPublicationTitle>Taiwan journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2211-5056</gtr:issn><gtr:outcomeId>5675e60b1f7f4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99E42A5C-7A18-4C12-9203-2B4A918D0800</gtr:id><gtr:title>Reply: Parsing the differences in affected with LHON: genetic versus environmental triggers of disease conversion.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56bfcebf084a63.01865212</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6D046A0-CC85-4E73-AA2D-D418452282E6</gtr:id><gtr:title>197th ENMC international workshop: Neuromuscular disorders of mitochondrial fusion and fission - OPA1 and MFN2 molecular mechanisms and therapeutic strategies: 26-28 April 2013, Naarden, The Netherlands.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>544972b3d877a7.65750366</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C13207F-601B-43FE-BB5D-3CA362624F84</gtr:id><gtr:title>Reply: Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7001a629b2674273a8490bc6a5efa6a3"><gtr:id>7001a629b2674273a8490bc6a5efa6a3</gtr:id><gtr:otherNames>Bannwarth S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56bfcec0840af0.86761516</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC981C90-8416-410E-968A-78728C14678C</gtr:id><gtr:title>Multi-system neurological disease is common in patients with OPA1 mutations.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>58a4ec2e414018.66160567</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4979ED3-3B63-4AB8-A27B-55F55196DA5D</gtr:id><gtr:title>Vertigo and vestibular abnormalities in spinocerebellar ataxia type 6.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>58a4ec2f1a9139.83214801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3B0684E-CE96-4DC8-B2AC-CEF4AD4A1ECF</gtr:id><gtr:title>A multiple sclerosis-like disorder in patients with OPA1 mutations.</gtr:title><gtr:parentPublicationTitle>Annals of clinical and translational neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2328-9503</gtr:issn><gtr:outcomeId>58a4eb855f22c2.16287739</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD598992-D343-4CE0-8981-7A9D8B029A39</gtr:id><gtr:title>Near-identical segregation of mtDNA heteroplasmy in blood, muscle, urinary epithelium, and hair follicles in twins with optic atrophy, ptosis, and intractable epilepsy.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9324030e73eb3a5421a31ea80edbd26"><gtr:id>d9324030e73eb3a5421a31ea80edbd26</gtr:id><gtr:otherNames>Spyropoulos A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>544972b5499058.78081155</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8B4CD50-A649-4901-821F-A2178F978727</gtr:id><gtr:title>Recessive spastic paraparesis associated with complex I deficiency due to MTHFR mutations.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cee64f0b98414289e07cdc3fdae9b5c1"><gtr:id>cee64f0b98414289e07cdc3fdae9b5c1</gtr:id><gtr:otherNames>Bathgate D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>K49ZaWwv2wp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C3552CF-F69B-4CDB-BCAB-5628119C532A</gtr:id><gtr:title>Reply: High prevalence of CHCHD10 mutations in patients with frontotemporal dementia from China.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7001a629b2674273a8490bc6a5efa6a3"><gtr:id>7001a629b2674273a8490bc6a5efa6a3</gtr:id><gtr:otherNames>Bannwarth S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56bfcebf342909.81372747</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F66377AF-332B-4204-A7D8-5212DD913F1D</gtr:id><gtr:title>Homozygous deletion in MICU1 presenting with fatigue and lethargy in childhood.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca96d1966f0778644c32e881ef5a5f3d"><gtr:id>ca96d1966f0778644c32e881ef5a5f3d</gtr:id><gtr:otherNames>Lewis-Smith D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>58a4eb868bd9a4.47360552</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B2E0F43-038B-48A4-975B-AE9EABFAD3BA</gtr:id><gtr:title>Visual and psychological morbidity among patients with autosomal dominant optic atrophy.</gtr:title><gtr:parentPublicationTitle>Acta ophthalmologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9722f6428465edb963f5cd639e62f91"><gtr:id>a9722f6428465edb963f5cd639e62f91</gtr:id><gtr:otherNames>Bailie M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1755-375X</gtr:issn><gtr:outcomeId>pm_13449_29_23452392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEA90D40-97F1-4140-BFDE-82A2E1333D24</gtr:id><gtr:title>Steroids for traumatic optic neuropathy.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>58a4ec2d898c67.97030058</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47530134-B35B-4561-92C8-21ECBA857944</gtr:id><gtr:title>Raised intraocular pressure as a potential risk factor for visual loss in Leber Hereditary Optic Neuropathy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f66f58488679f6122ce10c4e43a78fd9"><gtr:id>f66f58488679f6122ce10c4e43a78fd9</gtr:id><gtr:otherNames>Thouin A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13449_29_23667621</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64F40905-678F-4CC2-92A9-B16D39C7A897</gtr:id><gtr:title>Inherited eye-related disorders due to mitochondrial dysfunction.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5a9c20beddec99.46620753</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8ABF1A9D-4BDA-43D6-99BD-58B242171B3B</gtr:id><gtr:title>Reply: 'Behr syndrome' with OPA1 compound heterozygote mutations.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>544972b3083244.19023982</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81CAD8AC-9F60-4C16-BD03-F4A1AA4EDC4C</gtr:id><gtr:title>OPA1 mutations cause cytochrome c oxidase deficiency due to loss of wild-type mtDNA molecules.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>106DF0FC710</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C3A580F-FE22-4E62-A79E-89DC3211B37E</gtr:id><gtr:title>Erratum to: The neurological and ophthalmological manifestations of SPG4-related hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89b31b53bd8d22167e3e61b6f878f7e4"><gtr:id>89b31b53bd8d22167e3e61b6f878f7e4</gtr:id><gtr:otherNames>Guthrie G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56bfcebecf35f2.97578516</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07DEC4F1-E96D-4FBB-AADB-F37123C36309</gtr:id><gtr:title>Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.</gtr:title><gtr:parentPublicationTitle>Progress in retinal and eye research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1350-9462</gtr:issn><gtr:outcomeId>58a4ec2d57af86.09507455</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C3F8469-12E0-4A3F-AA3F-AD41D9C06DEA</gtr:id><gtr:title>Behr's Syndrome is Typically Associated with Disturbed Mitochondrial Translation and Mutations in theGene.</gtr:title><gtr:parentPublicationTitle>Journal of neuromuscular diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aec7e888ca27cb54fb6a199e4662974"><gtr:id>6aec7e888ca27cb54fb6a199e4662974</gtr:id><gtr:otherNames>Pyle A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0008-4581</gtr:issn><gtr:outcomeId>5675ebab9a419</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50BD4958-9B96-4234-B0EB-8CAFF5AB9386</gtr:id><gtr:title>Diagnostic investigations of patients with chronic progressive external ophthalmoplegia.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>pm_13449_29_23024221</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06AB1508-5574-4C4C-83E1-C312DB06EA67</gtr:id><gtr:title>Abnormal retinal thickening is a common feature among patients with ARSACS-related phenotypes.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>544972b46e0d47.86504164</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A67E71CC-82E8-4843-A9C9-4D4205A138C4</gtr:id><gtr:title>Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8e8b394438d706d8ec79a1881109468"><gtr:id>b8e8b394438d706d8ec79a1881109468</gtr:id><gtr:otherNames>Pfeffer G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>544972b4d569f7.72455775</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAE2F0AC-93AE-475A-BB4E-2F251EEA6409</gtr:id><gtr:title>OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b40f7fccb85bbddbb6ad3f8f75fb81fc"><gtr:id>b40f7fccb85bbddbb6ad3f8f75fb81fc</gtr:id><gtr:otherNames>Elachouri G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>ZRmjCy5Twqt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CBFAC15-4377-4107-8BB5-A69CFD4F38C7</gtr:id><gtr:title>Secondary mtDNA defects do not cause optic nerve dysfunction in a mouse model of dominant optic atrophy.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>58a4ec2ebae7a7.23671522</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CA9474A-388A-40EC-B6D5-15C521E64944</gtr:id><gtr:title>Late-onset sacsinopathy diagnosed by exome sequencing and comparative genomic hybridization.</gtr:title><gtr:parentPublicationTitle>Journal of neurogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aec7e888ca27cb54fb6a199e4662974"><gtr:id>6aec7e888ca27cb54fb6a199e4662974</gtr:id><gtr:otherNames>Pyle A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0167-7063</gtr:issn><gtr:outcomeId>544972b514a280.81859459</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DB1572A-CC7E-4682-93C5-E6BD106661CF</gtr:id><gtr:title>The Epidemiology of Leber Hereditary Optic Neuropathy in the North East of England.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>58a4eb861ae7c5.26791576</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70827A8E-CD92-455D-99B7-1346F6B32892</gtr:id><gtr:title>OPA1 increases the risk of normal but not high tension glaucoma.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>58a4ec2e919324.90440719</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5145C10-08E9-4902-8AEA-2AB69E50327B</gtr:id><gtr:title>Loss of function ofin mice induces deafness and cochlear outer hair cells' degeneration.</gtr:title><gtr:parentPublicationTitle>Cell death discovery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21ab813cf3529feeacd5df737851b9a3"><gtr:id>21ab813cf3529feeacd5df737851b9a3</gtr:id><gtr:otherNames>Buret L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2058-7716</gtr:issn><gtr:outcomeId>58a4eb871409f7.47762865</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>887A1209-902E-4814-ABFC-945E1B83EDDC</gtr:id><gtr:title>Mitochondrial DNA defects and selective extraocular muscle involvement in CPEO.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7da364a49ce4fb33fad59b22684eb777"><gtr:id>7da364a49ce4fb33fad59b22684eb777</gtr:id><gtr:otherNames>Greaves LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>iD4eLPy3B5U</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F38AC35-DE3F-49DF-A0F4-DD69F9CF9A58</gtr:id><gtr:title>Dysregulated mitophagy and mitochondrial organization in optic atrophy due to OPA1 mutations.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e2b35510da18c4d24ede0199ba63a6c"><gtr:id>4e2b35510da18c4d24ede0199ba63a6c</gtr:id><gtr:otherNames>Liao C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58a4eb8499ba94.17918863</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A370D1E3-8930-480D-BA57-EF97547F5F86</gtr:id><gtr:title>Efficient mitochondrial biogenesis drives incomplete penetrance in Leber's hereditary optic neuropathy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebed1cd795e0af5789caf713577a49fc"><gtr:id>ebed1cd795e0af5789caf713577a49fc</gtr:id><gtr:otherNames>Giordano C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>544972b4a59cb7.34696577</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>555C13A8-D0EC-48EB-A8B8-5A2A7395F84E</gtr:id><gtr:title>MFN2 mutations cause compensatory mitochondrial DNA proliferation.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/110e3dc589769ce84dec29b85162fcd3"><gtr:id>110e3dc589769ce84dec29b85162fcd3</gtr:id><gtr:otherNames>Sitarz KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_13449_29_22492563</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F642D91A-1AA4-4D7C-BE67-AC7A534BD7E0</gtr:id><gtr:title>Both mitochondrial DNA and mitonuclear gene mutations cause hearing loss through cochlear dysfunction.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d406079946f3d96dfc81e3954f097e6"><gtr:id>5d406079946f3d96dfc81e3954f097e6</gtr:id><gtr:otherNames>Kullar PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>58a4eb8654d079.10899858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC99E46D-CC55-46F0-A61E-38D3878CC130</gtr:id><gtr:title>Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies.</gtr:title><gtr:parentPublicationTitle>Ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0161-6420</gtr:issn><gtr:outcomeId>58a4ec2cca1b78.56694168</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C935D73F-D3FE-4CC1-A484-98B788332052</gtr:id><gtr:title>Universal heteroplasmy of human mitochondrial DNA.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45d5d618d31b1d170b90a2083007ae6c"><gtr:id>45d5d618d31b1d170b90a2083007ae6c</gtr:id><gtr:otherNames>Payne BA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_13449_29_23077218</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E26D95E-5035-4D25-8EEE-1041211CA5E4</gtr:id><gtr:title>Steroids for traumatic optic neuropathy.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>544972b5aa62c0.82712509</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F59B6E53-872D-4260-903B-8FBF0B534D28</gtr:id><gtr:title>Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/259bacbf5a696ae04385c90a10e4ab61"><gtr:id>259bacbf5a696ae04385c90a10e4ab61</gtr:id><gtr:otherNames>Gorman GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>56bfcec1266641.28155999</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>598899E8-4083-45BB-BD66-6C44D4AC9981</gtr:id><gtr:title>Dysfunctional mitochondrial maintenance: what breaks the circle of life?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_13449_29_22271662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>086B19E4-4A79-4174-B87B-629945480B78</gtr:id><gtr:title>Surgery for traumatic optic neuropathy.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>5a9c20bf4096d9.84676257</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9892DC56-79E2-481E-87C6-E4F2A7A956DB</gtr:id><gtr:title>A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7001a629b2674273a8490bc6a5efa6a3"><gtr:id>7001a629b2674273a8490bc6a5efa6a3</gtr:id><gtr:otherNames>Bannwarth S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>544972b3991009.65156799</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B539BCF6-20C2-4CC0-8748-4E0ADAB1FD01</gtr:id><gtr:title>Genetic manipulation for inherited neurodegenerative diseases: myth or reality?</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>58a4eb85d120b3.08054056</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47B9FB0D-8CFF-4611-BE1B-014244CC09FF</gtr:id><gtr:title>The m.13051G&amp;gt;A mitochondrial DNA mutation results in variable neurology and activated mitophagy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d5497e8825172e97b79fc5ceffcbfd2"><gtr:id>6d5497e8825172e97b79fc5ceffcbfd2</gtr:id><gtr:otherNames>Dombi E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58a4eb86c8ab07.81445736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>752A766C-73C2-44BB-882E-5C81EBA7EB17</gtr:id><gtr:title>A neurodegenerative perspective on mitochondrial optic neuropathies.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>58a4eb84df0062.74597997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F33A2EA-9810-47B0-933C-8B614D8855E2</gtr:id><gtr:title>The prevalence and natural history of dominant optic atrophy due to OPA1 mutations.</gtr:title><gtr:parentPublicationTitle>Ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0161-6420</gtr:issn><gtr:outcomeId>58a4ec2e0ffb48.79354788</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0400FE8-875E-41FB-B1CC-AC752152B76B</gtr:id><gtr:title>Variation in MAPT is not a contributing factor to the incomplete penetrance in LHON.</gtr:title><gtr:parentPublicationTitle>Mitochondrion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65eb931f142b9d0a96c1e2e4b5b1f6a7"><gtr:id>65eb931f142b9d0a96c1e2e4b5b1f6a7</gtr:id><gtr:otherNames>Hudson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1567-7249</gtr:issn><gtr:outcomeId>Ge1ynxv3rPH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08FEACCD-5849-4D86-BC31-33EED1318F05</gtr:id><gtr:title>Extraocular muscle atrophy and central nervous system involvement in chronic progressive external ophthalmoplegia.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97b274883a1e43c32b7d3477aca9ca99"><gtr:id>97b274883a1e43c32b7d3477aca9ca99</gtr:id><gtr:otherNames>Yu-Wai-Man C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>544972b5760793.65427925</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>878D1EBB-F02A-446D-8D71-6EE0A04AD08E</gtr:id><gtr:title>Cysteine Supplementation May be Beneficial in a Subgroup of Mitochondrial Translation Deficiencies.</gtr:title><gtr:parentPublicationTitle>Journal of neuromuscular diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bdc173cc903af2b23be1f55ff257851"><gtr:id>1bdc173cc903af2b23be1f55ff257851</gtr:id><gtr:otherNames>Bartsakoulia M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58a4ebc90c4d96.91277767</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E98E8D29-033A-4DE7-B76E-CD2431422654</gtr:id><gtr:title>POLG mutations cause decreased mitochondrial DNA repopulation rates following induced depletion in human fibroblasts.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/694f8cf95736b2802883926f906e6121"><gtr:id>694f8cf95736b2802883926f906e6121</gtr:id><gtr:otherNames>Stewart JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>ZS4YHM9gvmC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65A99194-FED3-4D74-A2FB-615A117E3B6D</gtr:id><gtr:title>Somatic mitochondrial DNA deletions accumulate to high levels in aging human extraocular muscles.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>58a4ec2dabea14.56476604</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B80DEE8-A2B2-46CF-88DB-649408446DE3</gtr:id><gtr:title>Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6eb36c645750836ba7b7fb501797c8d9"><gtr:id>6eb36c645750836ba7b7fb501797c8d9</gtr:id><gtr:otherNames>Klopstock T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_13449_29_23388409</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AD55D1F-DFD8-4A19-A585-A922489E1DCC</gtr:id><gtr:title>Mitochondrial dysfunction in glaucoma: closing the loop.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>pm_13449_29_22547661</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>294D77E9-BE66-48E3-BC32-87CA44EF3026</gtr:id><gtr:title>Dominant optic atrophy: novel OPA1 mutations and revised prevalence estimates.</gtr:title><gtr:parentPublicationTitle>Ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0161-6420</gtr:issn><gtr:outcomeId>pm_13449_29_23916084</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94557AE8-BC87-44DB-98B2-B78EB8642441</gtr:id><gtr:title>Reply: Sensorineural hearing loss in OPA1-linked disorders.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_13449_29_23650221</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE590437-563A-4200-BD1B-23B0E20AFB35</gtr:id><gtr:title>Exome sequencing in undiagnosed inherited and sporadic ataxias.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aec7e888ca27cb54fb6a199e4662974"><gtr:id>6aec7e888ca27cb54fb6a199e4662974</gtr:id><gtr:otherNames>Pyle A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56bfcec1b00e74.42090222</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BC9644F-FF4F-4B08-A161-6A4102B488EA</gtr:id><gtr:title>Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations.</gtr:title><gtr:parentPublicationTitle>Eye (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0950-222X</gtr:issn><gtr:outcomeId>58a4ec2d074c62.30616944</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59ABE392-CDBF-4A93-A7A1-E1022AECD538</gtr:id><gtr:title>Investigation of auditory dysfunction in Leber hereditary optic neuropathy.</gtr:title><gtr:parentPublicationTitle>Acta ophthalmologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1755-375X</gtr:issn><gtr:outcomeId>254EA10F7AB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF99E307-A28C-4074-B7AD-DB5D69E9C932</gtr:id><gtr:title>Reply: Spastic paraplegia in 'dominant optic atrophy plus' phenotype due to OPA1 mutation.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>58a4ec2c957741.63199835</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B58CEDA-0380-4296-9022-BFA2DFA0F14F</gtr:id><gtr:title>Reply: Two novel mutations in conserved codons indicate that CHCHD10 is a gene associated with motor neuron disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7001a629b2674273a8490bc6a5efa6a3"><gtr:id>7001a629b2674273a8490bc6a5efa6a3</gtr:id><gtr:otherNames>Bannwarth S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>544972b3397d02.26081146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13E1106F-A433-48ED-BA44-BD992CF224F6</gtr:id><gtr:title>Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8e8b394438d706d8ec79a1881109468"><gtr:id>b8e8b394438d706d8ec79a1881109468</gtr:id><gtr:otherNames>Pfeffer G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>544972b40efcb5.81929842</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A903CAA9-3B49-42F5-BBCE-8202C077FACA</gtr:id><gtr:title>Leber's hereditary optic neuropathy with late disease onset: clinical and molecular characteristics of 20 patients.</gtr:title><gtr:parentPublicationTitle>Orphanet journal of rare diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/334c6987dacabce24bde09808b699b63"><gtr:id>334c6987dacabce24bde09808b699b63</gtr:id><gtr:otherNames>Dimitriadis K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1750-1172</gtr:issn><gtr:outcomeId>56bfcda8e1f5e3.03391736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C636576F-3394-44F9-BCD8-A99ED8051900</gtr:id><gtr:title>Delayed Optochiasmal Arachnoiditis following Intervention for a Subarachnoid Haemorrhage.</gtr:title><gtr:parentPublicationTitle>Ophthalmology international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1750-1431</gtr:issn><gtr:outcomeId>5675e0409025f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>832951B6-22A8-4049-AF7F-CB40CD35AFBA</gtr:id><gtr:title>Evaluating the therapeutic potential of idebenone and related quinone analogues in Leber hereditary optic neuropathy.</gtr:title><gtr:parentPublicationTitle>Mitochondrion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1567-7249</gtr:issn><gtr:outcomeId>58a4eb84200ff4.71530285</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A855F795-43BF-4F7D-A7E4-131D98FD26BC</gtr:id><gtr:title>Therapeutic Approaches to Inherited Optic Neuropathies.</gtr:title><gtr:parentPublicationTitle>Seminars in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0271-8235</gtr:issn><gtr:outcomeId>56bfcec05cefd2.39982001</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4365D0CB-7B02-4D28-9669-A79B6D4AD97A</gtr:id><gtr:title>Leber hereditary optic neuropathy presenting in a 75-year-old man.</gtr:title><gtr:parentPublicationTitle>Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e183f90d0873ec594af1fe0d97529aa"><gtr:id>5e183f90d0873ec594af1fe0d97529aa</gtr:id><gtr:otherNames>Yu-Wai-Man P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1070-8022</gtr:issn><gtr:outcomeId>58a4ec2fdbeb44.19323136</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701386</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>A9061818-9B1E-495A-9617-7C77200827C2</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Eye</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>